ArticleFrontiers in cardiovascular medicine2025
Biological heart and brain ageing in subjects with cardiovascular diseases.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The heart-brain axis hypothesis suggests a bidirectional connection between the brain and the heart with relevant implications in health and disease. Cardiovascular diseases have been empirically linked to an increased risk of neurological diseases. However, it remains unclear to what extent different cardiovascular diseases affect brain health quantitatively across subjects and if that is associated with the extent the heart is affected by a disease. Therefore, this study aims to explore how cardiovascular diseases affect biological ageing of the brain and heart by quantifying the brain age gap (BAG) and the heart age gap (HAG) and relating the two to each other. Methods: This study used data from UK Biobank participants with available T1-weighted brain magnetic resonance imaging (MRI) scans, cardiac MRI-derived features, as well as pulse wave analysis cardiac measurements. This dataset included 7,500 healthy females and 6,684 healthy males. The data from healthy subjects was used to train biological brain age prediction machine learning models. For BAG computation, a convolutional neural network was trained based on the MRI data, while a CatBoost model was trained for HAG analyses based on the tabulated cardiac features. Individuals with cardiovascular diseases (F = 2,304, M = 2,925) in the UK Biobank were categorized using Phecodes and split based on sex and used to calculate the HAG and BAG for further analyses. Results: In 36 sex-specific cardiovascular disease groups, 24 showed significant differences from healthy subjects in the BAG and HAG distributions, whereas no strong correlations between the BAG and HAG distributions within disease groups were found. However, some diseases, such as hypotension and cardiac conduction disorders, showed sex-specific differences. Discussion: This study demonstrates that the combined use of HAG and BAG biomarkers provides a more comprehensive understanding of the interplay between cardiovascular and neurological ageing. The significant differences observed in disease groups, while lacking a strong correlation between the BAG and HAG, questions the generalizability of the heart-brain axis theory with respect to age gap biomarkers, suggesting potentially heterogeneous aging processes of the two systems that warrant further investigation in future work.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.